WOODCLIFF LAKE, N.J. & HENDERSON, Nev.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) (“Eagle” or the “Company”) and Spectrum Pharmaceuticals (NASDAQ:SPPI) (“Spectrum”) today announced that they have entered into a co-promotion agreement (“the agreement”) under which the Spectrum 32-person Corporate Accounts Sales Team will dedicate 80 percent of its time to selling and marketing up to six Eagle products over a period of at least 18 months. Spectrum will continue to maintain a separate sales force to market existing and potential hematology products.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
